| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/29/2013 | US20130225494 Formulations having an alpha v beta 3 antagonist and an alpha 2 beta 1 antagonist for anti-angionic therapy |
| 08/29/2013 | US20130225493 FGF-18 Truncated Variants Having Increased Receptor Specificity And Uses Thereof |
| 08/29/2013 | US20130225487 Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives |
| 08/29/2013 | US20130225480 Method of Treating Chronic Obstructive Pulmonary Disease |
| 08/29/2013 | US20130225479 Methods and Compositions for Treating Inflammation |
| 08/29/2013 | US20130224319 Compositions and Methods to Reduce Hangover and Reduce Blood Alcohol Levels After Alcohol Consumption |
| 08/29/2013 | US20130224310 Noscapine analogs and their use in treating cancers |
| 08/29/2013 | US20130224298 Two-Phase Preparation And Use Thereof For The Treatment Of Herpes |
| 08/29/2013 | US20130224296 Drug Formulations Using Water Soluble Antioxidants |
| 08/29/2013 | US20130224289 Gastric retained gabapentin dosage form |
| 08/29/2013 | US20130224286 Methods and compositions for treating pox virus infections |
| 08/29/2013 | US20130224280 Transdermal compositions and methods for treating stretch marks |
| 08/29/2013 | US20130224268 Topical delivery of hormonal and non hormonal nano formulations, methods of making and using the same |
| 08/29/2013 | US20130224251 Variants of group 6 allergens of the true grasses having reduced allergeneity due to mutagenesis of proline residues |
| 08/29/2013 | US20130224220 ErbB3 BINDING ANTIBODY |
| 08/29/2013 | US20130224210 Antibodies to matrix metalloproteinase 9 |
| 08/29/2013 | US20130224201 Antibodies to il-6 and use thereof |
| 08/29/2013 | US20130224200 Product and Process for Inhibition of Biofilm Development |
| 08/29/2013 | US20130224195 Substituted benzazoles and methods of their use as inhibitors of raf kinase |
| 08/29/2013 | US20130224192 Method for the prognosis of the progression of cancer |
| 08/29/2013 | US20130224190 Anti-cd19 antibody having adcc and cdc functions and improved glycosylation profile |
| 08/29/2013 | US20130224189 Tweak receptor |
| 08/29/2013 | US20130224188 CD47 Antibodies and Methods of Use Thereof |
| 08/29/2013 | US20130224186 Oxazole and thiazole compounds as ksp inhibitors |
| 08/29/2013 | US20130224176 Method of restoring the incretin effect |
| 08/29/2013 | US20130224170 Method of ameliorating oxidative stress and supplementing the diet |
| 08/29/2013 | US20130224160 Treatment of Vocal Cords with Autologous Dermal Fibroblast Formulation |
| 08/29/2013 | US20130224155 Compositions of microbiota and methods related thereto |
| 08/29/2013 | US20130224152 Spiro[2.4]heptanes for Treatment of Flaviviridae Infections |
| 08/29/2013 | US20130224151 Use of FAAH Inhibitors for Treating Abdominal, Visceral and Pelvic Pain |
| 08/29/2013 | US20130224150 IgG STIMULATED REMYELINATION OF PERIPHERAL NERVES |
| 08/29/2013 | US20130224149 Process for preparing antiviral compounds |
| 08/29/2013 | US20130224147 Macrocyclic serine protease inhibitors |
| 08/29/2013 | US20130224123 Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 08/29/2013 | US20130224118 Perhexiline for treating chronic heart failure |
| 08/29/2013 | US20130224111 Inhibition Of CD69 For Treatment Of Inflammatory Conditions |
| 08/29/2013 | US20130224110 Use of adenosine receptor signaling to modulate permeability of blood-brain barrier |
| 08/29/2013 | US20130224107 Heterocyclic derivates, preparation processes and medical uses thereof |
| 08/28/2013 | EP2629799A1 Topical base and active agent-containing compositions, and methods for improving and treating skin |
| 08/28/2013 | EP2629764A1 Compositions comprising a filler product and a compound of the tetracycline family used at a subantimicrobial dose |
| 08/28/2013 | CN1955280B Potency regeneration cell and culturing method thereof |
| 08/28/2013 | CN103269701A Hsp90 inhibitors for treating non-mall cell lung cancers in wild-<wbr/>type egfr and/or kras patients |
| 08/28/2013 | CN103269694A Pharmaceutical composition |
| 08/28/2013 | CN103267852A Application of fibroblast activation protein (FAP) alpha to preparation of pancreatic cancer prognosis kit |
| 08/28/2013 | CN103263677A MicroRNA molecule and application thereof in preparation of cancer drug |
| 08/28/2013 | CN103263673A Polysaccharide-gold-nanoparticle supermolecule assembled body as well as preparation method and application thereof |
| 08/28/2013 | CN103263669A Skin care composition and facial tissue with same |
| 08/28/2013 | CN103263668A Rifaximin anti-rectal dysfunction preparation |
| 08/28/2013 | CN102089006B Compositions and methods for producing vascular occlusion using solid-phase platelet binding agent |
| 08/28/2013 | CN101194017B Conjugate comprising P21 protein for the treatment of cancer |
| 08/27/2013 | US8519098 Composition of a polypeptide and an amphiphilic compound in an ionic complex and the use thereof |
| 08/27/2013 | US8519006 Use of sphingosine-1 phosphate (S1P) receptor agonists for the treatment of brain degenerative diseases |
| 08/27/2013 | US8519005 prevent, reduce, and/or reverse toxicities such as gastrointestinal toxicity, renal damage, mucosal damage, endothelial dysfunction, ischemia, and platelet dysfunction produced by antinflammatory drugs; concurrent administration of MAO inhibitor |
| 08/27/2013 | US8518999 Modulators of TNF-αsignaling |
| 08/27/2013 | US8518897 Method of treatment for cancers associated with elevated HER2 levels |
| 08/27/2013 | US8518890 Luteinizing hormone-releasing hormone receptor agonist leuprorelin, or antagonist with androgen receptor agonist for prophylaxis, treatment of prostate cancer; dehydroepiandrosterone, testosterone, dihydrotestosterone; non-steroidal androgen receptor agonist; estradiol, estrone, estriol, stilbestrol |
| 08/27/2013 | US8518869 Pharmaceutical combined preparation containing a therapeutic protein |
| 08/27/2013 | US8518655 Means for the diagnosis and therapy of CTCL |
| 08/27/2013 | US8518451 Thyroid hormone analogs and methods of use |
| 08/27/2013 | US8518443 Opioid agonist formulations with releasable and sequestered antagonist |
| 08/27/2013 | US8518422 Cosmetic or dermatological preparation comprising a nutrient medium phase |
| 08/27/2013 | US8518419 Method of treating diabetes |
| 08/27/2013 | CA2678722C Antihypertensive combination of valsartan and a calcium channel blocker |
| 08/27/2013 | CA2403425C Multivalent antibodies and uses therefor |
| 08/22/2013 | WO2013123272A1 Compositions and improved soft tissue replacement methods |
| 08/22/2013 | WO2013123270A1 Compositions and improved soft tissue replacement methods |
| 08/22/2013 | WO2013123138A2 Spiro [2.4]heptanes for treatment of flaviviridae infections |
| 08/22/2013 | WO2013122855A1 Methods of increasing lymphatic transport |
| 08/22/2013 | WO2013122624A1 Azetidinone cholesterol absorption inhibitor (ezetimibe) and omega 3 fatty acids (epa, dha, dpa) for the reduction of cholesterol and for the reduction of cardiovascular events |
| 08/22/2013 | WO2013122623A1 Omega 3 fatty acid for use as a prescription medical food and omega 3 fatty acid diagniostic assay for the dietary management of cardiovascular patients with cardiovascular disease (cvd) who are deficient in blood epa and dha levels |
| 08/22/2013 | WO2013122622A1 A method for treating obesity with anti-obesity formulations and omega 3 fatty acids for the reduction of body weight in cardiovascular disease patients (cvd) and diabetics |
| 08/22/2013 | WO2013122621A1 Omega 3 formulations for treatment of risk factors for cardiovascular disease and protection against sudden death |
| 08/22/2013 | WO2013122620A1 Statin and omega 3 fatty acids for reduction of apolipoprotein-b levels |
| 08/22/2013 | US20130219528 Novel treatment of prostate carcinoma |
| 08/22/2013 | US20130217951 7-(1,2,3-triazol-4-yl) pyrrolo [2,3-b] pyrazine derivatives |
| 08/22/2013 | US20130217949 Combinatorial methods and compositions for treatment of melanoma |
| 08/22/2013 | US20130217857 Erbb interface peptidomimetics and methods of use thereof |
| 08/22/2013 | US20130217776 Combination of a Serotonin Reuptake Inhibitor and Agomelatine |
| 08/22/2013 | US20130217747 Alpha-aminoamide derivatives useful in the treatment of restless legs syndrome |
| 08/22/2013 | US20130217741 Topical pharmaceutical compositions for treatment of skin damage |
| 08/22/2013 | US20130217725 Macrocyclic Inhibitors Of Hepatitis C Virus |
| 08/22/2013 | US20130217723 Pharmaceutical Composition Combining Tenatoprazole and an Anti-Inflammatory Agent |
| 08/22/2013 | US20130217722 Novel compound useful for the treatment of degenerative and inflammatory diseases |
| 08/22/2013 | US20130217721 Compositions and methods for detection and treatment of b-raf inhibitor-resistant melanomas |
| 08/22/2013 | US20130217715 Derivatives of pyrazolophenyl-benzenesulfonamide compounds and use thereof as antitumor agents |
| 08/22/2013 | US20130217714 Non-Flushing Niacin Analogues, and Methods of Use Thereof |
| 08/22/2013 | US20130217710 Methods for treating cancer |
| 08/22/2013 | US20130217709 Cyclic Amine Azaheterocyclic Carboxamides |
| 08/22/2013 | US20130217695 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/22/2013 | US20130217690 Novel 3-hydroxyisothiazole 1-oxide derivatives |
| 08/22/2013 | US20130217679 Compositions and Methods for Treatment of Neurodegenerative Disease |
| 08/22/2013 | US20130217664 Novel compounds useful for the treatment of degenerative and inflammatory diseases |
| 08/22/2013 | US20130217660 Novel prolylcarboxypeptidase inhibitors |
| 08/22/2013 | US20130217658 Pyrazole compounds acting against allergic, inflammatory and immune disorders |
| 08/22/2013 | US20130217657 Combination anti-inflammatory ophthalmic compositions |
| 08/22/2013 | US20130217646 Combination of alovudine and zidovudine in a molar ratio of 1:100 to 1:350 |
| 08/22/2013 | US20130217641 Compositions for treating helicobacter pylori infection |
| 08/22/2013 | US20130217633 Inhibitors of bcl-2 |
| 08/22/2013 | US20130217619 Linear peptide antibiotics |
| 08/22/2013 | US20130217617 Pyruvamide Compounds as Inhibitors of Dust Mite Group 1 Peptidase Allergen and Their Use |